NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Concord Biotech

Concord Biotech

Ahmedabad, Gujaratconcordbiotech.com

Overview

Concord Biotech Limited is an Indian, publicly-traded biopharmaceutical company focused on manufacturing Active Pharmaceutical Ingredients (APIs) and finished formulations through fermentation and semi-synthetic processes. The company's products serve various therapeutic areas, including immunosuppressants, oncology, and anti-fungals, and are exported to over 70 countries. It also offers contract research and manufacturing services (CRAMS).

Portfolio Companies

1

Investments

Concord Biotech investments
CompanyDateStageLead
Palvella TherapeuticsDec 2024Private PlacementCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersAhmedabad, Gujarat
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.